Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
In-house Produced PMMA- Versus PEEK-cages (NCT01607775)Universitätsmedizin Mannheim2009-02-01
Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation (NCT00842062)Pacira Pharmaceuticals, Inc2009-02-01
Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function (NCT00831532)Pfizer2009-02-01
To Evaluate the Response to Glucagon During Hypoglycemia (NCT00817271)AstraZeneca2009-02-01
A Study to Test the Combination of Two Different Kinds of Medications for the Treatment of Diabetes (NCT00853151)Eli Lilly and Company2009-02-01
A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers (NCT00850811)Peplin2009-02-01
Effect of Robot-assisted Training on Foot Drop in Multiple Sclerosis (NCT00872053)US Department of Veterans Affairs2009-02-01
A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165) (NCT00945321)Merck Sharp & Dohme LLC2009-02-01
Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer (NCT00845884)Rabin Medical Center2009-02-01
Effect of Lubiprostone on Methanogenesis and Bowel Function in Chronic Constipation. (NCT01190020)Augusta University2009-02-01
Relative Bioavailability and Food Effect Study (NCT00827515)Pfizer2009-02-01
Lag-3 and Gemcitabine for Treatment of Advanced Pancreas Cancer (NCT00732082)Washington University School of Medicine2009-02-01
Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes (NCT00850135)Stanford University2009-02-01
Safety of Polyphenon E in Multiple Sclerosis Pilot Study (NCT00836719)Louisiana State University Health Sciences Center in New Orleans2009-02-01
CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL (NCT00586391)Baylor College of Medicine2009-02-01
A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers (NCT00850681)Peplin2009-02-01
TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer (NCT00828529)Tibotec BVBA2009-02-01
Sickle Cell Disease Conditioning for Bone Marrow Transplant (NCT00968162)Emory University2009-02-01
Dose-finding Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and Bulky IIA Cervical Cancer (NCT00823186)Chang Gung Memorial Hospital2009-02-01
Safety Study of PEGPH20 Given to Patients With Advanced Solid Tumors (NCT00834704)Halozyme Therapeutics2009-02-01
Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV) (NCT00845650)Emergent BioSolutions2009-02-01
A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function (NCT00824590)Pfizer2009-02-01
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery (NCT00842452)Steven Waggoner, MD2009-02-01
Study Evaluating Single Ascending Doses Of ILS-920 (NCT00827190)Wyeth is now a wholly owned subsidiary of Pfizer2009-02-01
Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma (NCT00846131)Northwestern University2009-02-01
A Phase 1 Study To Estimate The Relative Bioavailability Of Fixed Combination Tablets Of Azithromycin And Chloroquine Compared To Co-Administered Individual Tablets Of Azithromycin And Chloroquine (NCT00844207)Pfizer2009-02-01
VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer (NCT00828789)Tibotec BVBA2009-02-01
Pharmacokinetics and Pharmacodynamics of Nasally Applied Esketamine (NCT00847418)University Hospital, Basel, Switzerland2009-02-01
Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer (NCT00901537)Loma Linda University2009-02-01
DNX-2401 (Formerly Known as Delta-24-RGD-4C) for Recurrent Malignant Gliomas (NCT00805376)DNAtrix, Inc.2009-02-01
Bioequivalence Study of Two Strengths of Two Different Metformin Tablets Administered to Healthy Male and Female Subjects (NCT02183571)Boehringer Ingelheim2009-02-01
A Study to Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers (NCT00839891)VIVUS LLC2009-02-01
B-type Natriuretic Peptide (BNP) in Human Hypertension (NCT00953472)Mayo Clinic2009-02-01
Intrapleural Gene Transfer for Pleural Mesothelioma (NCT01212367)Abramson Cancer Center at Penn Medicine2009-02-01
A Single-Dose Study of the Safety and Tolerability of REGN475(SAR164877) in Healthy Subjects (NCT00856310)Regeneron Pharmaceuticals2009-02-01
Cross -Over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel (NCT01096498)Bayer2009-02-01
BTT-1023 in Rheumatoid Arthritis (NCT00851240)Biotie Therapies Corp.2009-02-01
Comparative Bioavailability Study of Extended-release and Immediate-release Trazodone in Healthy Adult Volunteers (NCT00839072)Labopharm Inc.2009-02-01
Exercise Training in Patients With Non-cystic Fibrosis (CF) Bronchiectasis (NCT00885521)Bayside Health2009-02-01
Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel (NCT01096485)Bayer2009-02-01
Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of Subjects (NCT00824070)Bausch & Lomb Incorporated2009-02-01
Cardiac Autonomic Regulation Enhancement Through Exercise Trial (NCT00845091)The Miriam Hospital2009-02-01
Study to Evaluate Safety, Tolerability and Immunogenicity of Vaccine (UB 311) in Subjects With Alzheimer's Disease (NCT00965588)United Biomedical2009-02-01
Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL) (NCT00864942)Georgetown University2009-02-01
Role of Oral Glutathione in Skin Whitening (NCT01016080)Chulalongkorn University2009-02-01
A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors (NCT00811993)Hoffmann-La Roche2009-02-01
Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer (NCT00750269)Radiation Therapy Oncology Group2009-02-01
Exploratory Study of the Efficacy and Safety of Juvista 250ng When Administered Following Excision of Ear Lobe Keloids (NCT00836147)Renovo2009-02-01
EASI Access II --- Follow-up Study to the EASI Access Trial (NCT00740727)Massachusetts General Hospital2009-02-01
Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes (NCT01798264)Intarcia Therapeutics2009-02-01
A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder (NCT01094249)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2009-02-01
Study of Low Dose Nesiritide With or Without Sildenafil in Congestive Heart Failure Patients With Renal Dysfunction (NCT00818701)Mayo Clinic2009-02-01
Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects (NCT00836602)Bristol-Myers Squibb2009-02-01
Liver Regeneration Therapy Using Autologous Adipose Tissue Derived Stromal Cells (NCT00913289)Kanazawa University2009-02-01
Effect of Remote Ischemic Preconditioning on Cardiac Function After Cardiac Surgery (NCT00882622)Patrick Meybohm2009-02-01
Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women (NCT02592031)Merckle GmbH2009-02-01
Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses (NCT00841048)AstraZeneca2009-02-01
Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver Function (NCT00851227)Cumberland Pharmaceuticals2009-02-01
Drug-Drug Interaction Study Between Colchicine and Atorvastatin (NCT00960323)Mutual Pharmaceutical Company, Inc.2009-02-01
Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single Doses ofAZD2551 (NCT00860353)AstraZeneca2009-02-01
Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects (NCT00831506)Pfizer2009-02-01
A Phase 1b/2a, Open-Label, Multi-Center Study of Tivozanib (AV-951) in Combination With Paclitaxel in Subjects With Advanced or Metastatic Breast Cancer (NCT00717340)AVEO Pharmaceuticals, Inc.2009-02-01
Pilot Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy (NCT00837252)National Eye Institute (NEI)2009-02-01
Study to Evaluate Menses Induction in Women Administered Proellex (NCT00881608)Repros Therapeutics Inc.2009-02-01
Metabolic Health Benefits of Dairy Protein (NCT01761955)University of Manitoba2009-02-01
Study Evaluating Single Doses of ILV-095 in Healthy Japanese Male Subjects (NCT00822484)Wyeth is now a wholly owned subsidiary of Pfizer2009-02-01
The Effect of Rifapentine on Raltegravir (NCT00809718)The University of Texas Health Science Center at San Antonio2009-02-01
Azacitidine With Carboplatin and Paclitaxel for Newly Diagnosed Ovarian Cancer (NCT00842582)Loyola University2009-02-01
The Effect of Sodium Alginate on Appetite Sensation (NCT01101633)University of Copenhagen2009-02-01
Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC) (NCT00826449)M.D. Anderson Cancer Center2009-02-01
Cognitive Behavioral Therapy (CBT) for Tinnitus (NCT00724152)US Department of Veterans Affairs2009-02-01
Pharmacodynamic Study of Axitinib in Patients With Advanced Solid Malignancies (NCT00859118)University of Wisconsin, Madison2009-02-01
Cognitive Behavioral Treatment to Reduce Alcohol Use Among HIV-Infected Kenyans (NCT00792519)Brown University2009-02-01
White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local Therapy (NCT00779168)City of Hope Medical Center2009-01-29
Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults (NCT00880750)Shire2009-01-28
A Study of the Intratumoural Administration of CAVATAK to Head and Neck Cancer Patients (VLA-X06) (NCT00832559)Viralytics2009-01-27
A Study of Aprepitant (MK-0869) in Pediatric Participants Undergoing Surgery (MK-0869-148) (NCT00819039)Merck Sharp & Dohme LLC2009-01-26
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction (NCT00790842)PrECOG, LLC.2009-01-21
A Clinical Study to Assess the Effect of Food and Gender on the Pharmacokinetics of SRT2104 Administered as an Oral Suspension or Capsule Formulation to Normal Healthy Volunteers (NCT00938275)Sirtris, a GSK Company2009-01-20
Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects. (NCT00833378)GlaxoSmithKline2009-01-19
QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors (NCT00819169)NantCell, Inc.2009-01-16
Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers (NCT03644095)Reckitt Benckiser Inc.2009-01-16
A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects (NCT00823940)GlaxoSmithKline2009-01-13
Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas (NCT01445535)National Cancer Institute (NCI)2009-01-13
Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults (NCT00814489)GlaxoSmithKline2009-01-08
Lenalidomide and R-CHOP in B-cell Lymphoma (NCT00901615)Lymphoma Study Association2009-01-06
Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals (NCT00813228)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2009-01-06
AZD2281 in Combination With Liposomal Doxorubicin in Advanced Solid Tumours (NCT00819221)AstraZeneca2009-01-05
ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer (NCT00925769)Hoffmann-La Roche2009-01-01
The Efficacy of Parent Involvement in the Treatment of Adolescent Depression (NCT00883519)New York State Psychiatric Institute2009-01-01
A Study to Assess the Bioequivalence of Different Formulations of Risedronate in Healthy Male and Female Subjects (NCT00846196)Warner Chilcott2009-01-01
Brief Substance Use Intervention for Youth in Teen Court (NCT01464554)RAND2009-01-01
A Study of QBI-139 in Subjects With Advanced Solid Tumors (NCT00818831)Quintessence Biosciences, Inc.2009-01-01
Adipose CELL Derived Regenerative Endothelial Angiogenic Medicine (NCT01211028)University Hospital, Toulouse2009-01-01
Safety Study Using Photodynamic Therapy Light Therapy for Patients With Chest Wall Progression of Breast Cancer and Satellite Metastases of Melanoma (NCT00862901)Tufts Medical Center2009-01-01
Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients (NCT02646163)Replicor Inc.2009-01-01
Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer (NCT00823524)Asan Medical Center2009-01-01
Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies (NCT00824135)St. Jude Children's Research Hospital2009-01-01
Study of Concurrent Pemetrexed, Cisplatin and Radiotherapy in Local Advanced Non-Small Cell Lung Cancer (NCT00846443)Fudan University2009-01-01
Study of 72-Hour Infusion of ON 01910.Na in Patients With MDS or AML (NCT00854945)Traws Pharma, Inc.2009-01-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.